Advances in Cancer Immunotherapy

Society for Immunotherapy, in collaboration with the Earle A. Chiles Research Institute at Providence Cancer Center, will present an introductory, CME-certified program in Portland.

Session topics:

  • Adoptive T Cell Therapy with Variations
  • Blockade of the PD-1/PDL-1 Axis Inhibition
  • Combination and Other Immune Checkpoint Inhibitors/Agonists
  • CTLA-4 Blockade: Indications and Clinical Management
  • Cytokines (IL-2 and IFN): Indications and Clinical Management
  • Immunology 101
  • Principles of Immunotherapy
  • Radiation and Immunotherapy
  • Regulation of the Immune Response
  • Vaccines

The Clinical Immunology Society designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learn more about the event > 
Register by Sept. 30 >
Discounted early registration rate ends Sept. 16.